GeneReach Biotechnology Corp
TPEX:4171
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GeneReach Biotechnology Corp
TPEX:4171
|
TW |
|
D
|
Develia SA
WSE:DVL
|
PL |
|
J
|
JCDecaux SE
DUS:DCS
|
FR |
|
B
|
BCI Minerals Ltd
F:BC3
|
AU |
|
K
|
Kijcharoen Engineering Electric PCL
SET:KJL
|
TH |
|
D
|
Daiwa Securities Group Inc
XMUN:DSE
|
JP |
|
Strategic Education Inc
NASDAQ:STRA
|
US |
|
Mips AB
OTC:MPZAY
|
SE |
|
Avensia AB
F:5IY
|
SE |
|
P
|
Poled Co Ltd
KOSDAQ:487580
|
KR |
|
Seiren Co Ltd
F:1AB
|
JP |
|
S
|
Smith & Wesson Brands Inc
F:SWS
|
US |
|
E
|
Empire East Land Holdings Inc
XPHS:ELI
|
PH |
Dividends
Dividend Yield
GeneReach Biotechnology Corp
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
GeneReach Biotechnology Corp
Payout Ratio
GeneReach Biotechnology Corp
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for GeneReach Biotechnology Corp is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
GeneReach Biotechnology Corp
| Average Annual Return | -18.3% |
| Standard Deviation of Annual Returns | 15.49% |
| Max Drawdown | -86% |
| Market Capitalization | 1.1B TWD |
| Shares Outstanding | 58 060 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
GeneReach Biotechnology Corp's latest stock split occurred on Jul 28, 2023
The company executed a 1250-for-1000 stock split, meaning that for every 1000 shares held, investors received 1250 new shares.
Before the split, GeneReach Biotechnology Corp traded at 42.08 per share. Afterward, the share price was about 40.9.
The adjusted shares began trading on Jul 28, 2023. This was stock split number 3 in GeneReach Biotechnology Corp's history, following the previous one in Sep 13, 2022.